KARUNAKER SRIPATHI: Open Payments
NPI 1225087406 · PERRY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 15 payments from 10 companies in 2025. Trend: 2023 $366 · 2024 $306 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $150 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| BETA BIONICS, INC. | 1 | $119 |
| Novo Nordisk Inc | 3 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Lilly USA, LLC | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Abbott Laboratories | 1 | $22 |
| Amgen Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $10 |
Products named: Kerendia, CAPLYTA, iLet Bionic Pancreas, Ozempic, BREZTRI, MOUNJARO, TRELEGY ELLIPTA, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
